Kristin King

Chief Business Officer, FiteBac Technologies

Kristin King is an accomplished Biotech executive, serial intrapreneur, investor, and startup advisor. Kristin serves on Boston Harbor Angels Management team and an active Angel Investor. She is currently Chief Business Officer FiteBac Technologies, most recently Vice President Corporate Development, M&A at Defibtech, Nihon Kohden. With over 25 years’ leadership roles in corporate strategy, venture investment, commercial and technical development Kristin has championed healthcare innovation within both startups and Fortune 100 Global companies. She is an EIR with Yale Ventures and Board member Boston ENET. Kristin holds an MBA in Finance/Marketing from NYU Stern and a BS in bioengineering/mathematics from Syracuse. She is an avid scuba diver and environmental volunteer.